Clinical Trial Update: Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI. [Phase 4]

View source ↗

Summary

Phase 4 trial investigating whether adding carvedilolCR to ACE inhibitors provides vascular benefits in patients with type 2 diabetes and hypertension; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• ACE inhibitors
• carvedilolCR (carvedilol extended-release)

Snippet

Sponsor: University at Buffalo | Conditions: Diabetes Mellitus, Type 2, Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2024-04-16